Clinical Trial Update: Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fixed-dose versus concentration-controlled mycophenolate mofetil in active lupus nephritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Chulalongkorn University | Conditions: Lupus Nephritis | Phase 4 | Status: TERMINATED